By counteracting acetylcholine reduction in the synaptic cleft cholinesterase inhibitors, such as donepezil, are currently used as a symptomatic treatment to attenuate AD-related cognitive deterioration [92,93]. The gene discussed is BCHE; the disease is Alzheimer disease.